NovaBridge Biosciences: current_liabilities
| Value | {"amount": 16092000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-09-30) |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6f4026bd-2b53-4cb9-8143-10e3e5679fad
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-25-323791Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/current-liabilities/2025-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6f4026bd-2b53-4cb9-8143-10e3e5679fad
History
- no predecessors — first report